Companies with NDRs 10/23 Oct 23, 2019 07:17AM
Nabriva Therapeutics AG (NBRV) PT Lowered to $11 at SunTrust Robinson Humphrey Nov 13, 2018 03:50PM
Nabriva Therapeutics AG (NBRV) PT Lowered to $16 at SunTrust Robinson Humphrey Aug 14, 2018 07:27AM
Nabriva (NBRV) Prices 18.18M Share Common Offering at $2.75/Sh Jul 27, 2018 05:43AM
Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $50 Million Jul 26, 2018 08:00PM


May 21, 2018 12:59PM Nabriva (NBRV) Oversold on GI Side Effects - SunTrust
May 10, 2018 07:45AM Nabriva Therapeutics AG (NBRV) PT Lowered to $22 at SunTrust; Nabriva on Track to Release LEAP2 Phase III Data in Spring
Feb 28, 2018 07:54AM Nabriva (NBRV): KOL Call Underscores Strength of Commercial Opportunity - SunTrust
Sep 20, 2017 05:42AM Nabriva (NBRV) Prices 9.41M Common Share Offering at $8.50/Sh
Sep 19, 2017 08:53PM Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $80 Million
Sep 18, 2017 04:06PM Nabriva (NBRV) Commences $80M Public Offering of Ordinary Shares
Sep 18, 2017 04:06PM Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares
Sep 18, 2017 01:13PM Nabriva Therapeutics AG (NBRV) PT Raised to $24 at SunTrust Robinson Humphrey